Evofem to resubmit NDA for hormone-free contraceptive

By Sandi Wong | Jan 11, 2019 | 6:01 PM GMT

Evofem Biosciences Inc. (NASDAQ:EVFM) said on Dec. 17 that it plans to resubmit an NDA to FDA next